As the incidence of gastrointestinal tumors continues to rise in China, standardized diagnosis and treatment, along with the widespread application of innovative therapies, have become critical issues directly impacting patient survival and quality of life. To further integrate high-quality medical resources and promote the balanced development of regional academic levels, the "Future Chang'an - Gastrointestinal Tumor Academic Exchange Salon," hosted by the Chengdu High-tech Medical Association, is scheduled to be held grandly on December 25, 2025, in Chengdu, Sichuan.

    Themed "Future Chang'an," this conference symbolizes the pursuit of "long-term stability and sound governance" in the prevention and treatment of gastrointestinal tumors through continuous academic integration and exploration. The event will bring together top experts, academic leaders, and frontline clinicians in the field of gastrointestinal tumors from within and outside the province. It aims to address clinical pain points such as inconsistent diagnostic and treatment standards and difficulties in multidisciplinary collaboration through in-depth intellectual exchange and experience sharing, thereby deeply integrating cutting-edge concepts with local practices. In recent years, new technologies, new drugs, and personalized treatment plans in the field of gastrointestinal oncology have emerged continuously, with precision medicine and translational research profoundly changing the traditional treatment landscape.

    This salon will closely follow the pulse of the industry, adopting a format that combines "thematic reports" with "case studies." This approach not only conveys theoretical depth but also emphasizes practical value. Participating experts will analyze the difficulties and decision-making processes in diagnosis and treatment based on complex real-world cases, offering attendees a high-level, high-quality academic feast.